Substance

ID:455

Names and Identifiers
Brand Name
AtnaaAtropinAtropisolEyesulesIsopto-atropineTroyl tropateAtropairAtropin-flexiolenAtropine Sulfate Ansyr Plastic SyringeEquipinAtrosulfHomapin-10I-TropineIsopto AtropineOcu-TropineTropine tropateHomapin-5Minims AtropineAtropinolAtropenAtropine CareAtropine Sulfate S.O.P.
IUPAC Traditional name
hyoscyamine
Synonyms
Atropin [German]Atropina [Italian]DL-Tropyl tropateAtropine SulfateDL-HyoscyamineAtropine
IUPAC name
(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate
Registration numbers
CAS Number
Properties
Physical Property
Hydrophobicity(logP)
1.8
Solubility
Highly soluble (2200 mg/L)
Molecule Details
Drug Groups
approved
Description
An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae. [PubChem]
Indication
For the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides.
Pharmacology
Atropine, a naturally occurring belladonna alkaloid, is a racemic mixture of equal parts of d- and l-hyoscyamine, whose activity is due almost entirely to the levo isomer of the drug. Atropine is commonly classified as an anticholinergic or antiparasympathetic (parasympatholytic) drug. More precisely, however, it is termed an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine and other choline esters. Adequate doses of atropine abolish various types of reflex vagal cardiac slowing or asystole. The drug also prevents or abolishes bradycardia or asystole produced by injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. Atropine may also lessen the degree of partial heart block when vagal activity is an etiologic factor. Atropine in clinical doses counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters. However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure.
Toxicity
Oral, mouse: LD50 = 75 mg/kg. Symptoms of overdose includes widespread paralysis of parasympathetically innervated organs. Dry mucous membranes, widely dilated and nonresponsive pupils, tachycardia, fever and cutaneous flush are especially prominent, as are mental and neurological symptoms. In instances of severe intoxication, respiratory depression, coma, circulatory collapse and death may occur.
Affected Organisms
Humans and other mammals
Biotransformation
Much of the drug is destroyed by enzymatic hydrolysis, particularly in the liver. From 13 to 50% is excreted unchanged in the urine.
Absorption
Atropine is rapidly and well absorbed after intramuscular administration. Atropine disappears rapidly from the blood and is distributed throughout the various body tissues and fluids.
Half Life
3.0 ± 0.9 hours in adults. The half-life of atropine is slightly shorter (approximately 20 minutes) in females than males.
Protein Binding
The protein binding of atropine is 14 to 22% in plasma.
Elimination
Much of the drug is destroyed by enzymatic hydrolysis, particularly in the liver; from 13 to 50% is excreted unchanged in the urine.
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data